LC3C 抗体 (pSer12)
Quick Overview for LC3C 抗体 (pSer12) (ABIN2970987)
抗原
See all LC3C (MAP1LC3C) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- pSer12
-
纯化方法
- This antibody is first purified by protein A affinity chromatography. Then, the antibody fraction is peptide affinity purified in a 2-step procedure with peptides. The antibody is eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
-
免疫原
- Human LC3C (phospho-Ser12).
-
亚型
- IgG
-
-
anti-Microtubule-Associated Protein 1 Light Chain 3 gamma (MAP1LC3C) (pSer12) antibody
MAP1LC3C 适用: 人 WB, DB 宿主: 兔 Polyclonal RB10838-RB16769 unconjugated
anti-Microtubule-Associated Protein 1 Light Chain 3 gamma (MAP1LC3C) (AA 1-30) antibodyMAP1LC3C 适用: 人 ELISA, WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Microtubule-Associated Protein 1 Light Chain 3 gamma (MAP1LC3C) (AA 1-30) antibodyMAP1LC3C 适用: 人 ELISA, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Microtubule-Associated Protein 1 Light Chain 3 gamma (MAP1LC3C) (pSer12) antibodyMAP1LC3C 适用: 人 ELISA, WB, DB 宿主: 兔 Polyclonal unconjugated
anti-Microtubule-Associated Protein 1 Light Chain 3 gamma (MAP1LC3C) (Thr48) antibodyMAP1LC3C 适用: 人 WB, IHC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Microtubule-Associated Protein 1 Light Chain 3 gamma (MAP1LC3C) (AA 1-147) antibodyMAP1LC3C 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-Microtubule-Associated Protein 1 Light Chain 3 gamma (MAP1LC3C) (AA 1-147) antibodyMAP1LC3C 适用: 人 WB, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Microtubule-Associated Protein 1 Light Chain 3 gamma (MAP1LC3C) (AA 1-30), (N-Term) antibodyMAP1LC3C 适用: 人, 大鼠, 小鼠 WB, IHC (p), EIA 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- PBS with 0.09 % (W/V) sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
-
-
-
